603970 Stock Overview
Researches, develops, produces, and distributes agrochemicals in China and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Sino-Agri Leading Biosciences Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥13.95 |
52 Week High | CN¥21.20 |
52 Week Low | CN¥11.49 |
Beta | 0.15 |
11 Month Change | -5.87% |
3 Month Change | 9.33% |
1 Year Change | -14.68% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -28.70% |
Recent News & Updates
Recent updates
Shareholder Returns
603970 | CN Chemicals | CN Market | |
---|---|---|---|
7D | -3.3% | -1.8% | -1.2% |
1Y | -14.7% | -7.7% | 3.1% |
Return vs Industry: 603970 underperformed the CN Chemicals industry which returned -5.8% over the past year.
Return vs Market: 603970 underperformed the CN Market which returned 5.7% over the past year.
Price Volatility
603970 volatility | |
---|---|
603970 Average Weekly Movement | 5.8% |
Chemicals Industry Average Movement | 7.2% |
Market Average Movement | 7.8% |
10% most volatile stocks in CN Market | 12.0% |
10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 603970 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603970's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 855 | Yi Su | www.sino-agri-sal.com |
Sino-Agri Leading Biosciences Co.,Ltd researches, develops, produces, and distributes agrochemicals in China and internationally. It offers insecticides, fungicides, and herbicides. The company was founded in 2009 and is headquartered in Beijing, China.
Sino-Agri Leading Biosciences Co.,Ltd Fundamentals Summary
603970 fundamental statistics | |
---|---|
Market cap | CN¥3.75b |
Earnings (TTM) | CN¥218.13m |
Revenue (TTM) | CN¥10.61b |
17.2x
P/E Ratio0.4x
P/S RatioIs 603970 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603970 income statement (TTM) | |
---|---|
Revenue | CN¥10.61b |
Cost of Revenue | CN¥9.89b |
Gross Profit | CN¥723.26m |
Other Expenses | CN¥505.13m |
Earnings | CN¥218.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.81 |
Gross Margin | 6.82% |
Net Profit Margin | 2.06% |
Debt/Equity Ratio | 42.1% |
How did 603970 perform over the long term?
See historical performance and comparison